Long-Term Eplerenone Treatment in Peripapillary Pachychoroid Syndrome: A Case Series
Long-term eplerenone treatment appears effective in reducing choroidal thickness and improving visual outcomes in PPS patients. These findings suggest mineralocorticoid receptor antagonists may be valuable in managing pachychoroid spectrum disorders.
Authors
- Giovanni Alessio (ORCID: https://orcid.org/0000-0001-8313-4159)
- Giacomo Boscia (ORCID: https://orcid.org/0000-0002-8768-899X)
- Pasquale Viggiano (ORCID: https://orcid.org/0000-0002-0323-967X)
- Francesco Boscia (ORCID: https://orcid.org/0000-0002-5478-060X)
- Alba Chiara Termite
Institutions
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Case Reports in Ophthalmology
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1159/000546891
- Primary Topic
- Drug-Induced Ocular Toxicity
- Type
- article
- Field-Weighted Citation Impact
- 0.00